Error loading player: No playable sources found
65458
Session III: Control Strategies
Date
May 11, 2023
This product is not available for individual purchase, but it is available as part of the following products:
Speakers:
Vanessa Wong, AstraZeneca
Development of an Analytical Toolbox for the Detection, Confirmation, and Characterisation of Partially Reduced Species in Monoclonal Antibodies
Lars Geurink, Janssen Vaccines & Prevention B.V.
AQbD Method Control Strategy
Bastiaan Duivelshof, University of Geneva
How to Use Protein Specific Retention Behaviour to Improve the Characterization of Therapeutic Antibodies
Vanessa Wong, AstraZeneca
Development of an Analytical Toolbox for the Detection, Confirmation, and Characterisation of Partially Reduced Species in Monoclonal Antibodies
Lars Geurink, Janssen Vaccines & Prevention B.V.
AQbD Method Control Strategy
Bastiaan Duivelshof, University of Geneva
How to Use Protein Specific Retention Behaviour to Improve the Characterization of Therapeutic Antibodies
Session Chairs
Related Products
Session II: Analytical Challenges
Mercedes de Frutos, Institute of General Organic Chemistry (IQOG-CSIC)
Session V: Novel Technologies & Improvements in Analytical Technologies
Debbie van der Burg, MPYA Sci&Tech
Session IV: Regulatory Trends
Francesca Luciani, National Centre for the Control and Evaluation of Medicines (CNCF)
